Multiple-Dose Dalbavancin Regimens as the Predominant Treatment of Deep-Seated or Endovascular Infections: A Scoping Review

Off-label use of dalbavancin for deep-seated and endovascular infections has been increasing. We performed a scoping review to evaluate the evidence for use of multiple-dose dalbavancin regimens as the predominant therapy for these indications. Predominant therapy was defined as use of dalbavancin w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Margaret M, Preslaski, Candice R, Shihadeh, Katherine C, Hawkins, Kellie L, Jenkins, Timothy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562469/
https://www.ncbi.nlm.nih.gov/pubmed/34738025
http://dx.doi.org/10.1093/ofid/ofab486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562469/
https://www.ncbi.nlm.nih.gov/pubmed/34738025
http://dx.doi.org/10.1093/ofid/ofab486

Ejemplares similares